Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same

摘要

The invention relates to a novel compound termed NKp30 that is selectively expressed by all mature NK cells and that is involved in human natural cytoxicity as an activatory receptor, to new antibodies that bind to the NKp30 structure, and to the pharmaceutical and medicinal uses thereof.